ImCheck Therapeutics

About:

ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.

Website: http://www.imchecktherapeutics.com

Twitter/X: ImcheckThx

Top Investors: Andera Partners, Bpifrance, Alexandria Venture Investments, Earlybird Venture Capital, Invus

Description:

ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

Total Funding Amount:

193M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Marseille, Provence-Alpes-Cote d'Azur, France

Founded Date:

2015-01-01

Founders:

Alem Truneh, Benjamin Charles, Daniel Olive

Number of Employees:

11-50

Last Funding Date:

2024-08-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai